Synthesis of Arylpiperazine-Based CNS Ligands: Batch Disconnections and Their Continuous-Flow Implementation
- 1Department of Chemistry, Seoul Women’s University, Seoul 01797, Republic of Korea
Abstract
The 1-arylpiperazine unit recurs throughout centrally acting drugs, particularly ligands of serotonin and dopamine receptors, where its modular architecture—aryl group, piperazine core, linker, terminal fragment—has made it a durable design template. Three principal intermodule disconnections—the aryl-nitrogen bond, the piperazine-linker bond, and the linker-terminal bond—provide an organizing framework for the routes reviewed here. This review compares representative batch routes with reported continuous-flow implementations, distinguishing related methodological precedents, individual transformations in drug-specific routes, and linked multistep sequences. Three observations emerge from the reviewed examples. First, the drug-directed flow routes examined use preformed arylpiperazine building blocks. Second, dechlorination reported during cariprazine reductive amination highlights the importance of catalyst and solvent selection for that substrate. Third, the reported flow implementations address selected process challenges, while the multistep examples highlight the importance of compatibility between reaction and work-up operations. These observations inform a practical framework for evaluating batch and flow options for individual routes.
Related
- Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: Synthesis and biological evaluation
- SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling
- Direct Synthesis of CdSe Quantum Dot Inks in Polar Solvents with Conductive Ligands
- Synthesis of Quinoline- and Tetrahydroacridine-based SNN Ligands for Fe-catalyzed Olefin Hydrosilylation
- Synthesis of ultrasmall Fe-based nanoparticles with tunable magnetic properties: the effect of NHC ligands
BibTeX
@article{jeong2026synthesis,
title = {{Synthesis of Arylpiperazine-Based CNS Ligands: Batch Disconnections and Their Continuous-Flow Implementation}},
author = {Daeun Jeong and Ji Myoung Han and Ji Hoo Lee and In Young Oh and Ye Rim Cho and Yong-Ju Kwon},
journal = {Molecules},
year = {2026},
month = oct,
doi = {10.3390/molecules31203682},
url = {https://www.mdpi.com/1420-3049/31/20/3682},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Synthesis of Arylpiperazine-Based CNS Ligands: Batch Disconnections and Their Continuous-Flow Implementation
AU - Daeun Jeong
AU - Ji Myoung Han
AU - Ji Hoo Lee
AU - In Young Oh
AU - Ye Rim Cho
AU - Yong-Ju Kwon
PY - 2026
DA - 2026/10/14
JO - Molecules
DO - 10.3390/molecules31203682
UR - https://www.mdpi.com/1420-3049/31/20/3682
AB - The 1-arylpiperazine unit recurs throughout centrally acting drugs, particularly ligands of serotonin and dopamine receptors, where its modular architecture—aryl group, piperazine core, linker, terminal fragment—has made it a durable design template. Three principal intermodule disconnections—the aryl-nitrogen bond, the piperazine-linker bond, and the linker-terminal bond—provide an organizing framework for the routes reviewed here. This review compares representative batch routes with reported continuous-flow implementations, distinguishing related methodological precedents, individual transformations in drug-specific routes, and linked multistep sequences. Three observations emerge from the reviewed examples. First, the drug-directed flow routes examined use preformed arylpiperazine building blocks. Second, dechlorination reported during cariprazine reductive amination highlights the importance of catalyst and solvent selection for that substrate. Third, the reported flow implementations address selected process challenges, while the multistep examples highlight the importance of compatibility between reaction and work-up operations. These observations inform a practical framework for evaluating batch and flow options for individual routes.
SN - 1420-3049
ER -